ZYBERNO
Stock Report
Updated Aug 24, 2026

GOLDENWELL BIOTECH, INC. (GWLL)

Consumer Staples • OTC

$0.70

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
0.0/100
POOR BUSINESS
GOLDENWELL BIOTECH, INC. (GWLL) scores 0/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-208,729.1%)
Return on Capital (Capital Efficiency):CRITICAL (-297.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

GOLDENWELL BIOTECH, INC. (GWLL) stock report — Zyberno Score 0/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.70
Market Cap:$69.30M

Valuation Multiples (2)

P/S Ratio:1,260,000.00x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$69.49M

Price Action & Momentum (1)

% of 52-Week High:7.0%
B. Profitability Assessment

Margin Analysis (3)

Operating Margin Ttm:-208,729.1%
Net Margin Ttm:-512,940.0%
Ebitda Margin:-208,729.1%

TTM Performance (3)

Gross Margin Ttm:21.8%
Operating Margin Ttm:-208,729.1%
Net Margin Ttm:-512,940.0%

Yield Metrics (2)

Earnings Yield:$0.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.29x
Quick Ratio:0.29x
Cash Ratio:0.00x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-13.49x
Times Interest Earned:-13.49

Capital Structure (4)

Working Capital:-71,022.00
Cash And Cash Equivalents:0.00
Long Term Debt:$189.25K
Net Debt:$189.25K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $55.00
Linear Growth: -50.0%
📊 Click to view full GWLL Revenue analysis & methodology →
Cost Of Revenue Ttm:$43.00

Profitability Breakdown (2)

Gross profit TTM: $12.00
Linear Growth: -50.0%
📊 Click to view full GWLL Gross Profit analysis & methodology →
-$114.80K

Bottom Line Performance (3)

-$282.12K
Income Before Tax:-$34.38K
Ebitda Ttm:-114,801.00

Operating Expenses (5)

Operating Expenses:114,813.00
R And D Expense:0.00
Sga Expense:114,813.00
Income Tax Expense:$0.00
Interest Expense:8,400.00

Expense Ratios (1)

Ebitda Margin:-208,729.1%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$28.98K
Current Assets:$28.98K
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:427,173.00
Current Liabilities:100,000.00
Long Term Debt:$189.25K
Short Term Debt:$0.00

Equity & Capital (3)

Equity:-$398.20K
Retained Earnings:-$1.71M
Common Stock:300,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:0.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$35.99K$0.00

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$0.00
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (2)

EPS (Basic TTM):0.00
Earnings Per Share Ttm:-$0.00

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.00
Operating Cash Flow Per Share:-$0.00

Book Value & Capital (2)

Book Value Per Share:-$0.00
Cash Per Share:-999.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.00x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:0.00
Quality Score:15.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-50.0%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-50.0%
Book Value Growth Rate (Linear):-50.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:GWLL
Company Name:GOLDENWELL BIOTECH, INC.
Sector:Consumer Staples
Industry:Food and Kindred Products
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:99.00M
Shares Outstanding Basic:99.00M
Shares Outstanding Diluted:99.00M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-24 12:43:40 UTC
Data Timestamp:2026-08-24T12:43:40.066370
Scroll to Top